Why the study?
It was uncertain whether cryoablation for pulmonary vein isolation is effective and safe in patients with symptomatic and drug-refractory paroxysmal AF with episode durations under 24 hours.
Does cryoablation of pulmonary veins isolation reduce recurrence of atrial tachyarrhythmia and stroke/TIA in patients with paroxysmal AF within 24-hour episode duration compared to those with episodes lasting ≥24 hours?
Does cryoablation of pulmonary veins isolation reduce recurrence of atrial tachyarrhythmia and stroke/TIA in patients with paroxysmal AF within 24-hour episode duration compared to those with episodes lasting ≥24 hours?
Cryoablation for paroxysmal AF with episodes lasting less than 24 hours is associated with significantly lower rates of arrhythmia recurrence and stroke/TIA compared to episodes lasting 24 hours or longer.
AF episodes <24 h associated with lower recurrence and stroke/TIA post-cryoablation; hypothesis-generating, should not yet change practice.
Background: Paroxysmal atrial fibrillation (AF) is closely related to pathophysiologic processes and clinical outcomes. However, it is uncertain whether cryoablation of pulmonary veins isolation is effective and safe for patients of symptomatic and drug-refractory AF type within 24-hour episode duration. Methods: The patients were designed into Group A (253 patients of paroxysmal AF within 24-hour episode duration) and Group B (253 patients of paroxysmal AF lasted for 24 hours or longer) on a 1:1 basis by identical propensity scores. Mortality, stroke/transient ischemic attack (TIA) and complications relevant to the cryoablation procedure were compared and recurrence of atrial tachyarrhythmia was analyzed for clinical independent predictors. Results: The rate of atrial tachyarrhythmia recurrence was 21.74% in Group A and 30.04% in Group B, respectively (P=0.042). At 12-month follow-up from procedure, lower incidences of stroke/TIA endpoint of the patients were observed in Group A compared with Group B by Kaplan–Meier analysis [HR 0.34 (0.13–0.87), P= 0.025]. No significant differences about mortality and complications relevant to the cryoablation procedure were observed between Group A and Group B. Moreover, adjusted multivariable Cox regression analysis showed that < 24-hour paroxysmal AF type (HR 0.644, 95% CI: 0.455–0.913, P=0.014) and left atrium diameter (>40 mm) (HR 1.696, 95% CI: 1.046–2.750, P=0.032) were independently associated with the incidence of recurrence of atrial tachyarrhythmia in the study. Conclusions: Cryoablation of AF within 24-hour episode duration is effective and safe for patients with paroxysmal AF.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: